ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
ChemoCentryx Announces Presentation of Data from Ongoing Phase Ib Clinical Trial of CCR2 Inhibitor C
January 22, 2017ChemoCentryx, Inc., announced the presentation of results from its immuno-oncology program at the American Society of Clinical Oncology (ASCO) 2017 Gastrointestinal Cancers Symposium being held January 19-21, 2017 in San Francisco, California. -
AstraZeneca broadens first-line immuno-oncology NSCLC development programme
January 18, 2017AstraZeneca provided an update Tuesday on its late-stage immuno-oncology development programme in first-line non-small-cell lung cancer (NSCLC). -
Lilly and Merck expand immuno-oncology collaboration
January 13, 2017Eli Lilly and Merck (MSD) have expanded an existing immuno-oncology collaboration, through a subsidiary, to add a new study of Lilly's Lartruvo (olaratumab) with Keytruda (pembrolizumab) in patients with previously treated advanced or metastatic soft tiss -
Pieris Pharmaceuticals and Servier Forge Strategic Immuno-oncology Co-development Alliance
January 06, 2017Pieris Pharmaceuticals, Inc. announced a broad collaboration in immuno-oncology (IO).
Pharma Sources Insight January 2025
